Copy
View this email in your browser
COVID-19 Update
February 8, 2021
IowaBio wants to provide our members useful information during the COVID-19 pandemic. This newsletter compiles information on state, federal and industry action to combat the virus and its impacts.

If your company is helping respond to COVID-19, IowaBio wants to know about it. Please, send any information about what your biotechnology company or organization is doing to help, to Jessica Hyland at Jessica@iowabio.org.

If IowaBio can assist you in getting information out, connecting with public officials, or support your company in another way, please do not hesitate to reach out.

Past IowaBio COVID-19 Update newsletters are now available at www.iowabio.org/COVID19 and can be found under the Industry News tab on the IowaBio website.

Iowa Update

On Friday, Governor Reynolds signed a new Public Health Disaster proclamation that relaxes existing public health measures effective Sunday, February 7th, 2021 while continuing critical regulatory relief to those on the frontlines of COVID19 recovery for an additional 30 days.  
 
The proclamation removes requirements to wear masks and for mandatory social distancing in businesses like restaurants, bars, spas and gyms, while strongly encouraging Iowans, businesses, and organizations to take reasonable public health measures consistent with guidance from the Iowa Department of Public Health. 
 
The proclamation is also modified to reflect changes due to the passage of Senate File 160, which requires schools to provide for in person instruction. 
 
The proclamation can found online here. To read more about the changes click here.
 
IowaBio Member Highlights

Last week IowaBio member Johnson & Johnson announced their submission of application to the U.S. FDA for Emergency Use Authorization of its investigational single-shot Janssen COVID-19 vaccine candidate.

Johnson & Johnson intends to distribute the vaccine to the U.S. government immediately following authorization, and expects to supply 100 million doses to the U.S. in the first half of 2021.

The Company's EUA submission is based on topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose vaccine met all primary and key secondary endpoints. The Company expects to have product available to ship immediately following authorization.
 
The Janssen investigational vaccine is compatible with standard vaccine distribution channels. If authorized, Janssen’s investigational single-dose vaccine is estimated to remain stable for two years at -4°F (-20°C), at least three months of which can be stored in most standard refrigerators at temperatures of 36°F–46°F (2°-8°C). The Company will ship the vaccine using the same cold chain technologies it uses today to transport other innovative medicines.
 
For more information on the Company’s multi-pronged approach to helping combat the pandemic, visit: www.jnj.com/coronavirus.
 
Key Statistics

Iowa
The overall number of vaccines administered is 341,923 an increase of 52,186 since Friday, with 162,839 receiving their first dose of the Pfizer or Moderna vaccine and 89,542 receiving their second dose. To find vaccine providers in your county, click here or scroll to the bottom of the vaccine dashboard.

Currently, IDPH has reported on the state’s coronavirus dashboard, 324,669 Iowans have tested positive, up 1,368 from our update Friday morning, with a total of 1,495,205 tested. 75 additional deaths were reported since our last update, bringing the total to 5,108 deaths. Now 294,121 Iowans have recovered. The total 14 day rolling average positivity rate is 8.8% the past 7-day average is 6.6%. The latest on hospitalizations, including how many patients have been admitted in the last 24 hours can be found here. There are currently 318 hospitalized patients.

School district statistics including positivity rates by county can be found here. According to guidance issued by the Iowa Department of Education, schools may petition to go to hybrid or online learning with less than 50 percent in-person instruction when the per county percentage positivity rates are above 15 percent in a county on average over the past 14 days (rolling average) AND 10% absenteeism among students is expected for in-person learning. School district waiver requests and whether they are granted or denied are listed here.

Currently 2 (of 99) counties are at or above a 15 percent positivity rate over the past 14 days. Click here to search county data for today.

US
Total Cases 26,761,047
Total Deaths 460,582

World
Total Cases 106,227,670
Total Deaths 2,318,696

BIO Pipeline Tracker
818 Unique compounds in development
202 vaccines
233 antivirals
383 treatments
Sincerely,
Jessica

Jessica Hyland, J.D.
Executive Director
Iowa Biotechnology Association
Cell: (515) 822-1315
Office: (515) 327-9156
Fax: (515) 327-1407
jessica@iowabio.org
www.iowabio.org
Copyright © 2021 Iowa Biotech Association, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp